摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 3-amino-5-fluorobenzo[b]thiophene-2-carboxylate | 835912-83-9

中文名称
——
中文别名
——
英文名称
methyl 3-amino-5-fluorobenzo[b]thiophene-2-carboxylate
英文别名
3-amino-5-fluoro-benzo[b]thiophene-2-carboxylic acid methyl ester;methyl 3-amino-5-fluoro-1-benzothiophene-2-carboxylate
methyl 3-amino-5-fluorobenzo[b]thiophene-2-carboxylate化学式
CAS
835912-83-9
化学式
C10H8FNO2S
mdl
——
分子量
225.243
InChiKey
DWVFEGXDEUEYHF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    144-146°C

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    80.6
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2934999090

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 3-amino-5-fluorobenzo[b]thiophene-2-carboxylateN-甲基哌嗪 作用下, 以 N-甲基吡咯烷酮 为溶剂, 反应 4.0h, 以75%的产率得到5-fluoro-benzo[b]thiophen-3-ylamine
    参考文献:
    名称:
    WO2008/20306
    摘要:
    公开号:
  • 作为产物:
    参考文献:
    名称:
    Tricyclic aminopyrimidine histamine H4 receptor antagonists
    摘要:
    This report discloses the development of a series of tricyclic histamine H-4 receptor antagonists. Starting with a low nanomolar benzofuranopyrimidine HTS hit devoid of pharmaceutically acceptable properties, we navigated issues with metabolism and solubility to furnish a potent, stable and water soluble tricyclic histamine H-4 receptor antagonist with desirable physiochemical parameters which demonstrated efficacy a mouse ova model. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.08.014
点击查看最新优质反应信息

文献信息

  • MODULATORS OF CCR9 RECEPTOR AND METHODS OF USE THEREOF
    申请人:Anderson Eric C.
    公开号:US20100029753A1
    公开(公告)日:2010-02-04
    Provided are compounds that are modulators of CCR9 receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, provided are methods for treating or ameliorating diseases associated with modulation of CCR9 receptor activity.
    提供了调节CCR9受体活性的化合物,含有这些化合物的组合物以及使用这些化合物和组合物的方法。在某些实施例中,提供了用于治疗或改善与调节CCR9受体活性相关的疾病的方法。
  • Cu-Catalyzed Denitrogenative Transannulation of 3-Aminoindazoles To Assemble 1-Aminoisoquinolines and 3-Aminobenzothiophenes
    作者:Yao Zhou、Ya Wang、Yixian Lou、Qiuling Song
    DOI:10.1021/acs.orglett.9b02288
    日期:2019.11.15
    We disclose a novel Cu-catalyzed denitrogenative transannulation of 3-aminoindazoles to afford diverse functionalized 3-aminobenzothiophenes and 1-aminoisoquinolines, in which denitrogenative transannulation of 3-aminoindazoles is reported for the first time. This transformation proceeds via an "extrude-and-sew" strategy with an unprecedented radical reactivity of 3-aminoindazoles.
  • US8178699B2
    申请人:——
    公开号:US8178699B2
    公开(公告)日:2012-05-15
  • [EN] ISOINDOLE DERIVATIVES<br/>[FR] DÉRIVÉS D'ISOINDOLE
    申请人:PFIZER PROD INC
    公开号:WO2008020306A2
    公开(公告)日:2008-02-21
    [EN] This invention relates to compounds of formula (I) or pharmaceutically acceptable salts thereof, a process of making these compounds, pharmaceutical compositions containing one or more of these compounds or their salts, and their use for the treatment of schizophrenia, bipolar disorder, or other central nervous system disorders.
    [FR] La présente invention concerne des composés de formule (I) ou leurs sels pharmaceutiquement acceptables, un procédé de fabrication de ces composés, des compositions pharmaceutiques contenant un ou plusieurs de ces composés ou leurs sels et leur utilisation pour le traitement de la schizophrénie, du trouble bipolaire ou d'autres affections du système nerveux central.
  • [EN] MODULATORS OF CCR9 RECEPTOR AND METHODS OF USE THEREOF<br/>[FR] MODULATEURS DU RÉCEPTEUR CCR9 ET LEURS PROCÉDÉS D'UTILISATION
    申请人:ENCYSIVE PHARMACEUTICALS INC
    公开号:WO2009017719A2
    公开(公告)日:2009-02-05
    Provided are compounds that are modulators of CCR9 receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, provided are methods for treating or ameliorating diseases associated with modulation of CCR9 receptor activity.
查看更多

同类化合物